RHOA and ischemia: We have previously shown that MMPs and the RhoA/ROCK pathway inhibitor simvastatin have a protective effect on cardiac systolic function in an acute ischemia–reperfusion model by inhibiting the RhoA pathway independently of reducing MMP-2 activity [18].